{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:33:42Z","timestamp":1791218022400,"version":"4.1.0"},"reference-count":122,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Carnitine is essential for the mitochondrial transport of long-chain fatty acids and thus plays a pivotal role in energy metabolism, particularly in metabolically active organs, such as skeletal and cardiac muscle. In patients with dialysis, carnitine homeostasis is disrupted because of the reduced synthesis, impaired renal reabsorption, and carnitine loss during extracorporeal procedures. Carnitine deficiency is linked to a wide range of clinical manifestations, including muscle weakness, treatment-resistant anemia, intradialytic hypotension, mental disorder, and cardiovascular disease. This review provides a comprehensive overview of the physiological function of carnitine, elucidates the underlying mechanisms of carnitine deficiency in patients with dialysis, and explores the clinical consequences. Furthermore, the efficacy and limitations of L-carnitine supplementation in clinical practice are discussed based on the current literature. A better understanding of the pathophysiological and clinical relevance of carnitine deficiency may help facilitate personalized therapeutic strategies for patients with kidney diseases.<\/jats:p>","DOI":"10.3390\/nu17132084","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:37:21Z","timestamp":1750739841000},"page":"2084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Carnitine Deficiency in Chronic Kidney Disease: Pathophysiology, Clinical Implications, and Therapeutic Perspectives"],"prefix":"10.3390","volume":"17","author":[{"given":"Yusuke","family":"Kaida","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-1809","authenticated-orcid":false,"given":"Kensei","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"},{"name":"Research Institute of Medical Mass Spectrometry, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5583-3996","authenticated-orcid":false,"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine\u2013metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.nutr.18.1.39","article-title":"Carnitine metabolism and its regulation in microorganisms and mammals","volume":"18","author":"Rebouche","year":"1998","journal-title":"Annu. Rev. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1320.003","article-title":"Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism","volume":"1033","author":"Rebouche","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1681\/ASN.V133708","article-title":"Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review","volume":"13","author":"Hurot","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000355751","article-title":"Influence of L-carnitine supplementation on serum lipid profile in hemodialysis patients: A systematic review and meta-analysis","volume":"38","author":"Huang","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/j.ajkd.2008.05.031","article-title":"Effects of L-carnitine on dialysis-related hypotension and muscle cramps: A meta-analysis","volume":"52","author":"Lynch","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1196\/annals.1320.005","article-title":"Carnitine replacement in end-stage renal disease and hemodialysis","volume":"1033","author":"Calvani","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s11255-021-02835-5","article-title":"Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: A meta-analysis","volume":"53","author":"Zhu","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhou, J., and Yang, T. (2020). The efficacy of L-carnitine in improving malnutrition in patients on maintenance hemodialysis: A meta-analysis. Biosci. Rep., 40.","DOI":"10.1042\/BSR20201639"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chewcharat, A., Chewcharat, P., Liu, W., Cellini, J., Phipps, E.A., Melendez Young, J.A., and Nigwekar, S.U. (2022). The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0271307"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jn\/136.8.2131","article-title":"The discovery of a vitamin role for carnitine: The first 50 years","volume":"136","author":"Wolf","year":"2006","journal-title":"J. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10408369209114601","article-title":"Clinical and biochemical aspects of carnitine deficiency and insufficiency: Transport defects and inborn errors of beta-oxidation","volume":"29","author":"Angelini","year":"1992","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_15","first-page":"3S57","article-title":"Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy","volume":"17","author":"Tein","year":"2002","journal-title":"J. Child. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mam.2004.06.002","article-title":"Carnitine acyltransferases and their influence on CoA pools in health and disease","volume":"25","author":"Ramsay","year":"2004","journal-title":"Mol. Aspects Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0272-6386(03)00112-4","article-title":"The role of carnitine in normal and altered fatty acid metabolism","volume":"41","author":"Hoppel","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","article-title":"The role of the carnitine system in human metabolism","volume":"1033","author":"Foster","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1320.004","article-title":"Carnitine deficiency disorders in children","volume":"1033","author":"Stanley","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/BJ20110544","article-title":"Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli","volume":"439","author":"Pochini","year":"2011","journal-title":"Biochem. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0065-3101(24)00155-5","article-title":"New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency","volume":"34","author":"Stanley","year":"1987","journal-title":"Adv. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.nu.03.070183.001313","article-title":"Carnitine","volume":"3","author":"Borum","year":"1983","journal-title":"Annu. Rev. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1749-6632.2002.tb02119.x","article-title":"Mitochondrial decay in the aging rat heart: Evidence for improvement by dietary supplementation with acetyl-L-carnitine and\/or lipoic acid","volume":"959","author":"Hagen","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1620\/tjem.224.209","article-title":"Single dose administration of L-carnitine improves antioxidant activities in healthy subjects","volume":"224","author":"Cao","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2891-13-79","article-title":"Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: A randomized, placebo-controlled trial","volume":"13","author":"Lee","year":"2014","journal-title":"Nutr. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0531-5565(01)00116-4","article-title":"Carnitine as a free radical scavenger in aging","volume":"36","author":"Panneerselvam","year":"2001","journal-title":"Exp. Gerontol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5653\/cerm.2019.03440","article-title":"Effect of L-carnitine on the expression of the apoptotic genes Bcl-2 and Bax","volume":"47","author":"Vardiyan","year":"2020","journal-title":"Clin. Exp. Reprod. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lee, Y.G., Chou, H.C., Chen, Y.T., Tung, S.Y., Ko, T.L., Buyandelger, B., Wen, L.L., and Juan, S.H. (2022). L-Carnitine reduces reactive oxygen species\/endoplasmic reticulum stress and maintains mitochondrial function during autophagy-mediated cell apoptosis in perfluorooctanesulfonate-treated renal tubular cells. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-08771-3"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12967-025-06341-5","article-title":"Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: Beyond fatty acid oxidation","volume":"23","author":"Xiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Virmani, M.A., and Cirulli, M. (2022). The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052717"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.ddmec.2009.02.001","article-title":"Carnitine homeostasis, mitochondrial function, and cardiovascular disease","volume":"6","author":"Sharma","year":"2009","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1139\/cjpp-2015-0305","article-title":"l-carnitine protects human hepatocytes from oxidative stress-induced toxicity through Akt-mediated activation of Nrf2 signaling pathway","volume":"94","author":"Li","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s11064-008-9775-9","article-title":"Cellular stress response: A novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity","volume":"33","author":"Calabrese","year":"2008","journal-title":"Neurochem. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.freeradbiomed.2024.01.017","article-title":"Carnitine functions as an enhancer of NRF2 to inhibit osteoclastogenesis via regulating macrophage polarization in osteoporosis","volume":"213","author":"Yang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10787-023-01376-w","article-title":"L-Carnitine augments probenecid anti-inflammatory effect in monoiodoacetate-induced knee osteoarthritis in rats: Involvement of miRNA-373\/P2X7\/NLRP3\/NF-\u03baB milieu","volume":"32","author":"Mahfouz","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bcp.2012.12.021","article-title":"L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-\u03b3 expression","volume":"85","author":"Zambrano","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mansour, H.H., El Kiki, S.M., Ibrahim, A.B., and Omran, M.M. (2021). Effect of l-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF\/PPAR\u03b3\/MAPK pathways. Arch. Biochem. Biophys., 704.","DOI":"10.1016\/j.abb.2021.108866"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.kint.2023.09.020","article-title":"IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury","volume":"105","author":"Taguchi","year":"2024","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Koohpeyma, F., Siri, M., Allahyari, S., Mahmoodi, M., Saki, F., and Dastghaib, S. (2021). The effects of L-carnitine on renal function and gene expression of caspase-9 and Bcl-2 in monosodium glutamate-induced rats. BMC Nephrol., 22.","DOI":"10.1186\/s12882-021-02364-4"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sun, C., Guo, Y., Cong, P., Tian, Y., and Gao, X. (2023). Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice. Nutrients, 15.","DOI":"10.3390\/nu15061359"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11011-021-00715-6","article-title":"Acetyl-L-carnitine confers neuroprotection against lipopolysaccharide (LPS) -induced neuroinflammation by targeting TLR4\/NF\u03baB, autophagy, inflammation and oxidative stress","volume":"36","author":"Alizadeh","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1203\/00006450-198702000-00018","article-title":"The renal handling of carnitine in patients with selective tubulopathy and with Fanconi syndrome","volume":"21","author":"Steinmann","year":"1987","journal-title":"Pediatr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI113353","article-title":"Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome","volume":"81","author":"Gahl","year":"1988","journal-title":"J. Clin. Invest."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ito, S., Taguchi, K., Kodama, G., Kubo, S., Moriyama, T., Yamashita, Y., Yokota, Y., Nakayama, Y., Kaida, Y., and Shinohara, M. (JCI Insight, 2025). Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease, JCI Insight, in press.","DOI":"10.1172\/jci.insight.179362"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e140695","DOI":"10.1172\/JCI140695","article-title":"Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J. Clin. Invest."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: A nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Mol. Aspects Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0024-3205(96)00343-8","article-title":"Carnitine metabolism in chronic liver disease","volume":"59","year":"1996","journal-title":"Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bst0140673","article-title":"Inter-tissue relationships in the synthesis and distribution of carnitine","volume":"14","author":"Hoppel","year":"1986","journal-title":"Biochem. Soc. Trans."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0304-4165(80)90133-6","article-title":"Tissue distribution of carnitine biosynthetic enzymes in man","volume":"630","author":"Rebouche","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3610417","article-title":"Carnitine biosynthesis in mammals","volume":"361","author":"Vaz","year":"2002","journal-title":"Biochem. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/jn\/117.6.1024","article-title":"gamma-Butyrobetaine hydroxylase activity is not rate limiting for carnitine biosynthesis in the human infant","volume":"117","author":"Olson","year":"1987","journal-title":"J. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000185137","article-title":"Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects","volume":"50","author":"Wanner","year":"1988","journal-title":"Nephron"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/07315724.1986.10720124","article-title":"Carnitine as an essential nutrient","volume":"5","author":"Borum","year":"1986","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI111281","article-title":"Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport","volume":"73","author":"Rebouche","year":"1984","journal-title":"J. Clin. Invest."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arr.2010.02.005","article-title":"Mechanistic contribution of carnitine deficiency to geriatric frailty","volume":"9","author":"Crentsil","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Sawicka, A.K., Hartmane, D., Lipinska, P., Wojtowicz, E., Lysiak-Szydlowska, W., and Olek, R.A. (2018). l-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function. Nutrients, 10.","DOI":"10.3390\/nu10020255"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1053\/j.gastro.2009.08.016","article-title":"Carnitine in parenteral nutrition","volume":"137","author":"Borum","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3476(83)80027-4","article-title":"Carnitine deficiency in premature infants receiving total parenteral nutrition: Effect of L-carnitine supplementation","volume":"102","author":"Penn","year":"1983","journal-title":"J. Pediatr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12967-019-1818-2","article-title":"Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease","volume":"17","author":"Zhou","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41467-025-56955-y","article-title":"BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma","volume":"16","author":"Liao","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/00365518209168117","article-title":"Gamma-butyrobetaine hydroxylase in human kidney","volume":"42","author":"Lindstedt","year":"1982","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nut.2017.08.015","article-title":"Red meat intake in chronic kidney disease patients: Two sides of the coin","volume":"46","author":"Mafra","year":"2018","journal-title":"Nutrition"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2125.2007.02926.x","article-title":"A pharmacokinetic model for L-carnitine in patients receiving haemodialysis","volume":"64","author":"Fornasini","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Iorember, F.M. (2018). Malnutrition in Chronic Kidney Disease. Front. Pediatr., 6.","DOI":"10.3389\/fped.2018.00161"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.jrn.2024.04.005","article-title":"Dysgeusia and Chronic Kidney Disease: A Scoping Review","volume":"34","author":"Sguanci","year":"2024","journal-title":"J. Ren. Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Rahbar Saadat, Y., Abbasi, A., Hejazian, S.S., Hekmatshoar, Y., Ardalan, M., Farnood, F., and Zununi Vahed, S. (2025). Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04057-8"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.kint.2017.06.012","article-title":"Adaptor protein is a new therapeutic target in chronic kidney disease","volume":"92","author":"Isaka","year":"2017","journal-title":"Kidney Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1212\/WNL.31.7.819","article-title":"Primary systemic carnitine deficiency. II. Renal handling of carnitine","volume":"31","author":"Engel","year":"1981","journal-title":"Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1053\/ajkd.2003.50099","article-title":"Carnitine and hemodialysis","volume":"41","author":"Bellinghieri","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":"Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"ref_76","first-page":"999","article-title":"The effect of valproic acid on plasma carnitine levels","volume":"145","author":"Opala","year":"1991","journal-title":"Am. J. Dis. Child."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biopha.2005.06.014","article-title":"Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity","volume":"60","author":"Origlia","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ito, T., Tsukahara, K., Sato, H., Shimizu, A., and Okamoto, I. (2021). Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08471-7"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/1078-0432.CCR-10-1239","article-title":"Cisplatin-induced downregulation of OCTN2 affects carnitine wasting","volume":"16","author":"Lancaster","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0272-6386(03)00113-6","article-title":"Dialysis-related carnitine disorder and levocarnitine pharmacology","volume":"41","author":"Evans","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.jrn.2006.10.006","article-title":"Advances in carnitine in chronic uremia","volume":"17","author":"Guarnieri","year":"2007","journal-title":"J. Ren. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/ajkd.2001.27408","article-title":"Carnitine metabolism in uremia","volume":"38","author":"Guarnieri","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_83","first-page":"208","article-title":"Frequency of low carnitine levels in children on dialysis","volume":"22","year":"2006","journal-title":"Adv. Perit. Dial."},{"key":"ref_84","first-page":"36","article-title":"Absolute and Relative Carnitine Deficiency in Patients on Hemodialysis and Peritoneal Dialysis","volume":"10","author":"Naseri","year":"2016","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1542-4758.2012.00679.x","article-title":"L carnitine in hemodialysis patients","volume":"16","author":"Vertolli","year":"2012","journal-title":"Hemodial. Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/1744-9987.12712","article-title":"Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review","volume":"22","author":"Akizawa","year":"2018","journal-title":"Ther. Apher. Dial."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2010.11.006","article-title":"Pharmacological use of L-carnitine in uremic anemia: Has its full potential been exploited?","volume":"63","author":"Bonomini","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000014474","article-title":"Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin","volume":"19","author":"Matsumoto","year":"2001","journal-title":"Blood Purif."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kuwasawa-Iwasaki, M., Io, H., Muto, M., Ichikawa, S., Wakabayashi, K., Kanda, R., Nakata, J., Nohara, N., Tomino, Y., and Suzuki, Y. (2020). Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis. Nutrients, 12.","DOI":"10.3390\/nu12113371"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/0886022X.2020.1719847","article-title":"Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: A cross-sectional observational study","volume":"42","author":"Kaneko","year":"2020","journal-title":"Ren. Fail."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kaneko, S., Yanai, K., Kitano, T., Miyazawa, H., Hirai, K., Ookawara, S., and Morishita, Y. (2021). Change in Anemia by Carnitine Supplementation in Patients Undergoing Peritoneal Dialysis: A Retrospective Observational Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.767945"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00467-006-0408-8","article-title":"Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis","volume":"22","author":"Verrina","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s004670000423","article-title":"Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis","volume":"15","author":"Lilien","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0272-6386(03)00115-X","article-title":"The role of carnitine in myocardial dysfunction","volume":"41","author":"Pauly","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0008-6363(99)00263-1","article-title":"Cardiac fatty acid uptake and transport in health and disease","volume":"45","author":"Glatz","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.ajkd.2015.09.010","article-title":"Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial","volume":"67","author":"Higuchi","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1253\/circj.72.926","article-title":"L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis","volume":"72","author":"Sakurabayashi","year":"2008","journal-title":"Circ. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000084853","article-title":"Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients","volume":"25","author":"Kazmi","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.3390\/nu6125992","article-title":"Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: A randomized controlled trial","volume":"6","author":"Higuchi","year":"2014","journal-title":"Nutrients"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"ref_101","first-page":"39","article-title":"Chronic Oral L-Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions","volume":"30","author":"Miller","year":"2016","journal-title":"JIMD Rep."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Ji, W., Zhang, B., Liu, J., Li, K., Jia, J., Fan, F., Jiang, J., Wang, X., and Zhang, Y. (2025). Relationship Between Level of Trimethylamine Oxide and the Risk of Recurrent Cardiovascular Events in Patients with Acute Myocardial Infarction. Nutrients, 17.","DOI":"10.2139\/ssrn.5191104"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/FJC.0000000000000197","article-title":"Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients","volume":"65","author":"Fukami","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Takashima, H., Maruyama, T., and Abe, M. (2021). Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients, 13.","DOI":"10.3390\/nu13041219"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000186280","article-title":"Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis","volume":"57","author":"Siami","year":"1991","journal-title":"Nephron"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1990.290","article-title":"Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects","volume":"38","author":"Ahmad","year":"1990","journal-title":"Kidney Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41430-018-0348-y","article-title":"Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: A randomized controlled trial","volume":"73","author":"Maruyama","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/1744-9987.13576","article-title":"l-carnitine supplementation vs cycle ergometer exercise for physical activity and muscle status in hemodialysis patients: A randomized clinical trial","volume":"25","author":"Yano","year":"2021","journal-title":"Ther. Apher. Dial."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1744-9987.12553","article-title":"Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial","volume":"21","year":"2017","journal-title":"Ther. Apher. Dial."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/0019-5359.24678","article-title":"Results of a single blind, randomized, placebo-controlled clinical trial to study the effect of intravenous L-carnitine supplementation on health-related quality of life in Indian patients on maintenance hemodialysis","volume":"60","author":"Rathod","year":"2006","journal-title":"Indian J. Med. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/ajkd.1998.v32.pm9708610","article-title":"Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients","volume":"32","author":"Sakurauchi","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/rej.2012.1399","article-title":"Evidence for a positive association between serum carnitine and free testosterone levels in uremic men with hemodialysis","volume":"16","author":"Sakai","year":"2013","journal-title":"Rejuvenation Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/ajkd.1998.v32.pm9708611","article-title":"Quality of life during and between hemodialysis treatments: Role of L-carnitine supplementation","volume":"32","author":"Sloan","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3945\/ajcn.113.062802","article-title":"L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: A systematic review and meta-analysis","volume":"99","author":"Chen","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_115","first-page":"484","article-title":"Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients","volume":"23","author":"Naini","year":"2012","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00467-021-05080-1","article-title":"Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: A randomized placebo-controlled clinical trial","volume":"36","author":"Zarezadeh","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/ndt\/gfl356","article-title":"Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients","volume":"21","author":"Duranay","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1542-4758.2010.00476.x","article-title":"Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia","volume":"14","author":"Shakeri","year":"2010","journal-title":"Hemodial. Int."},{"key":"ref_119","first-page":"1155","article-title":"The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients","volume":"22","author":"Suchitra","year":"2011","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/rej.2013.1459","article-title":"Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis","volume":"16","author":"Fukami","year":"2013","journal-title":"Rejuvenation Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2174\/1570180814666170216102632","article-title":"L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis","volume":"14","author":"Tashiro","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_122","first-page":"453","article-title":"Patients with primary carnitine deficiency treated with L-carnitine are alive and doing well-A 10-year follow-up in the Faroe Islands","volume":"64","author":"Abrahamsen","year":"2023","journal-title":"JIMD Rep."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/13\/2084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:57:12Z","timestamp":1760032632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/13\/2084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":122,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["nu17132084"],"URL":"https:\/\/doi.org\/10.3390\/nu17132084","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}